Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've missed two weeks of Mounjaro, the guidance is clear: do not take two pens to catch up. Inject your next scheduled dose as soon as you remember, then continue weekly from that point. Missing two consecutive doses is common, and the clinical path forward is straightforward — though there's an important consideration about tolerability that's worth understanding before you re-start. Mounjaro (tirzepatide) is a prescription-only medicine, and any concerns about re-starting after a gap should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the decision most people are wrestling with: pick up where you left off, or treat re-starting like an earlier step in treatment? The answer depends on how long you've been on your current dose and how well you tolerated it before the gap.
If you had settled comfortably on a dose (nausea was manageable, appetite suppression was working, no significant GI upset) then continuing at that same dose is often reasonable. The Mounjaro prescribing information and NHS guidance both indicate you should resume at your usual dose and carry on the weekly schedule. The NHS tirzepatide medicines page confirms that a missed dose should be taken as soon as possible if the next scheduled injection is more than four days away; if fewer than four days remain before that next dose, skip the missed one and continue normally.
For a two-week gap, that rule means one thing practically: don't try to double-dose. Take the next single injection on your regular day and move forward. Two weeks without tirzepatide means the drug has largely cleared from your system, levels drop significantly between doses even at steady state, and after a fortnight there is very little active drug remaining.
One thing worth gently setting aside: the idea that missing two weeks means you've "reset" entirely and must start again from 2.5mg. That's not automatically the case. The starting dose exists to help your body adjust to a new medicine, not as a compulsory re-entry point every time there's a gap. Whether a step-back is appropriate is a clinical call, not a blanket rule, and it's one your prescriber is best placed to make based on your history.
There are situations where re-starting at a lower strength is genuinely the right move. If you were mid-titration (for example, you had recently moved to 5mg or 7.5mg and hadn't fully settled at that level before missing two weeks) your prescriber might suggest returning to the previous dose for a month before moving up again.
The reasoning is tolerability. When you first step up to a higher dose, the first few weeks can bring the most pronounced nausea, reduced appetite and GI effects. A two-week break interrupts that adjustment process. Jumping back to a higher dose without re-settling can mean those effects hit harder than if you'd been consistent. That said, many people tolerate re-starting at the same dose without any issue.
If you're currently on Mounjaro 5mg or above and you've had a smooth run so far, the probability of tolerating re-start at the same level is reasonably high. If you found the dose challenging even before the gap, a step-back is worth discussing. Either way, a quick message to your prescriber before re-injecting is never wasted time. If you're unsure which dose you were on or want guidance on the full titration schedule, the Mounjaro starter dose page explains how the titration steps are structured.
For context on what a longer break means (and when the guidance changes more substantially) the advice around missing three or more weeks of Mounjaro is worth reading alongside this page.
A two-week break in treatment is not a failure, and it doesn't erase what's been achieved. Appetite-suppressing effects do reduce once tirzepatide levels fall, which is why some people notice hunger returning or eating patterns shifting during a gap. That's the drug's mechanism at work, not a sign that treatment has stopped working permanently.
Weight-wise, most people see minimal change over two weeks off treatment, especially if they've been following the lifestyle changes recommended alongside it. Others notice some regain. The NHS guidance on weight management injections consistently emphasises that these medicines work best alongside sustained dietary and activity changes, and those behaviours don't disappear because a dose was missed.
Once you re-start and the drug re-establishes itself (usually within a week or two), appetite suppression typically returns. Consistent dosing from that point is what matters most for steady, long-term progress. If your gap was due to supply issues, you can read more about how Mounjaro cost and supply work in the UK private market.
For broader context on managing doses (including what happens if you've only missed a single injection) the full missed Mounjaro dose guide covers the scenarios in detail. And if you've missed just a week rather than two, this page on one missed week applies more precisely to that situation.
Most two-week gaps are uncomplicated. But there are times when reaching out to a prescriber first is the right call. Contact your prescriber before re-injecting if: you experienced a significant side effect that caused the break (severe nausea, vomiting, abdominal pain); you've started a new medicine or supplement during the gap; you're unsure which dose you were on; or your circumstances have changed in a way that might affect suitability.
Urgent medical attention (not a call to your pharmacy) is the right route if you develop severe, persistent stomach pain that radiates to your back, with or without vomiting. That symptom pattern can indicate pancreatitis, a known but infrequent risk with GLP-1 medicines that the MHRA highlighted in a safety update in January 2026. It is rare, but it warrants same-day assessment, not waiting to see if it passes.
For everything else, our prescribers are available seven days a week for aftercare support. If you'd like a clinical review of your situation (including whether to continue at your current dose or step back) you can contact the team directly, or if you're new to treatment, start your free consultation to be assessed by a GPhC-registered prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.